Endothelin-1 Augments Therapeutic Potency of Human Mesenchymal Stem Cells via CDH2 and VEGF Signaling

In our previous study, we identified differences in the levels of CDH2 and vascular endothelial growth factor (VEGF) between effective and ineffective clones of human umbilical cord blood (hUCB) mesenchymal stem cells (MSCs), with regard to the infarcted rat myocardium. In this study, we compared ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eun Ju, Hwang, Injoo, Kim, Gi-Hwan, Moon, Dodam, Kang, Su Yeon, Hwang, In-Chang, Lee, Seo-Yeon, Marie, P.J., Kim, Hyo-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545354/
https://www.ncbi.nlm.nih.gov/pubmed/31194009
http://dx.doi.org/10.1016/j.omtm.2019.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545354/
https://www.ncbi.nlm.nih.gov/pubmed/31194009
http://dx.doi.org/10.1016/j.omtm.2019.05.003

Ejemplares similares